Endovascular Treatment for Steno-Occlusive Iliac Artery Disease: Safety and Long-Term Outcome

We evaluated safety and long-term outcome of endovascular therapy for steno-occlusive iliac artery disease. All endovascular procedures of iliac artery lesions performed at our institution between 2001 and 2014 (n = 676) were retrospectively analyzed. The overall technical success rate was 99% and yielded 100% for stenoses (n = 596) and 95% for chronic total occlusions (n = 80). Lesion complexity defined by the Trans-Atlantic Inter-Society Consensus (TASC) II classification had no impact on success rates (TASC A + B vs C + D; 99.5% vs 98.6%, P = .359). During a median follow-up of 11 months, the overall rate of restenosis was 9.4%. After 1 and 3 years, the primary patency rates were 94% and 86% and the secondary patency rate was 100%, respectively. The TASC II classification had no impact on long-term patency rates (TASC A + B vs C + D; 86% vs 81%). In a multivariable analysis, stent diameter remained the only significant predictor for restenosis (hazard ratio: 0.58; 95% confidence interval: 0.41%-0.81%; P = .002). In this single-center retrospective study, endovascular therapy for steno-occlusive iliac artery disease was associated with high technical and clinical success rates as well as an excellent long-term patency rate irrespective of lesion complexity.

[1]  J. Tazaki,et al.  Efficacy and Safety of Endovascular Therapy for Aortoiliac TASC D Lesions , 2017, Angiology.

[2]  L. Norgren,et al.  An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries , 2015, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[3]  Z. Jing,et al.  Endovascular therapy for long-segment atherosclerotic aortoiliac occlusion. , 2014, Journal of vascular surgery.

[4]  F. Farrokhyar,et al.  Clinical Outcomes of 5358 Patients Undergoing Direct Open Bypass or Endovascular Treatment for Aortoiliac Occlusive Disease: A Systematic Review and Meta-Analysis , 2013, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[5]  I. van Herzeele,et al.  BRAVISSIMO: 12-month results from a large scale prospective trial. , 2012, The Journal of cardiovascular surgery.

[6]  C. Schwencke,et al.  Long term data of endovascularly treated patients with severe and complex aortoiliac occlusive disease. , 2012, The Journal of cardiovascular surgery.

[7]  Raimund Erbel,et al.  [2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases]. , 2012, Revue medicale de Liege.

[8]  J. Ricco,et al.  Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. , 2011, Journal of vascular surgery.

[9]  K. Yeung,et al.  A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. , 2010, Journal of vascular surgery.

[10]  L. Oğuzkurt,et al.  Technique, Complication, and Long-Term Outcome for Endovascular Treatment of Iliac Artery Occlusion , 2010, CardioVascular and Interventional Radiology.

[11]  Melissa J. Neisen,et al.  Endovascular management of aortoiliac occlusive disease. , 2009, Seminars in interventional radiology.

[12]  S. Hans,et al.  Results of endovascular therapy and aortobifemoral grafting for Transatlantic Inter-Society type C and D aortoiliac occlusive disease. , 2008, Surgery.

[13]  F. Neumann,et al.  Acute and Long-Term Outcome of Endovascular Therapy for Aortoiliac Occlusive Lesions Stratified According to the TASC Classification: A Single-Center Experience , 2008, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[14]  G. Simonetti,et al.  Percutaneous Treatment in Iliac Artery Occlusion: Long-Term Results , 2008, CardioVascular and Interventional Radiology.

[15]  J. Corson,et al.  Long-term outcome following stent reconstruction of the aortic bifurcation and the role of geometric determinants. , 2008, Annals of vascular surgery.

[16]  H. van Overhagen,et al.  Long-term results of primary stent placement to treat infrarenal aortic stenosis. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.

[18]  S. Stevens,et al.  Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. , 2003, Journal of vascular surgery.

[19]  D. Baim,et al.  Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. , 2002, Journal of the American College of Cardiology.

[20]  Y. Graaf,et al.  Health-Related Quality of Life After Angioplasty and Stent Placement in Patients With Iliac Artery Occlusive Disease Results of a Randomized Controlled Clinical Trial , 1999 .

[21]  AlbertSchömig,et al.  Vessel Size and Long-Term Outcome After Coronary Stent Placement , 1998 .

[22]  R D Safian,et al.  The Importance of Acute Luminal Diameter in Determining Restenosis After Coronary Atherectomy or Stenting , 1992, Circulation.

[23]  D. Brewster,et al.  Clinical and Anatomical Considerations for Surgery in Aortoiliac Disease and Results of Surgical Treatment , 1991, Circulation.

[24]  E. Barrett-Connor,et al.  TABLE 1 Prevalence of PAD by traditional assessment : intermittent claudication and pulse palpation % Claudication % Pulse abnormalities Rose Femoral Posterior Dorsalis n Rose , 2005 .

[25]  L. Norgren,et al.  An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.). , 2015, Annals of vascular diseases.

[26]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[27]  K. Ouriel,et al.  Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. , 2006, Journal of vascular surgery.

[28]  David Sacks,et al.  Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. , 2003, Journal of vascular and interventional radiology : JVIR.

[29]  Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[30]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.

[31]  Y. van der Graaf,et al.  Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. , 1999, Circulation.

[32]  D. Sacks,et al.  Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. Technology Assessment Committee. , 1997, Journal of vascular and interventional radiology : JVIR.

[33]  C M Gibson,et al.  Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. , 1993, Journal of the American College of Cardiology.